Skip to content
عاجل
Epson and Classera Partner to Advance Digital Learning in Saudi Arabia’s Schoolsالسعودية: تعاون بين إبسون وكلاسيرا لتطوير التعلّم الرقمي في مدارس المملكةاليوم الوطني السعودي الـ96.. وطنٌ راسخ واقتصادٌ قوي وإعلامٌ يواكب المستقبلمتوسطة الأبناء بالرياض تحتفي باليوم الوطني 4 أيام.. والعرضة تتصدر المشهدRUA AlHaram AlMakki Expands International Collaboration Through Strategic Agreements in Malaysia and Bruneiرؤى الحرم المكي ورؤى المدينة القابضة توسعان التعاون الدولي عبر اتفاقيتين استراتيجيتين في برونايShaping Mega Projects 2026 Turns to Delivery as Expo 2030 Riyadh Accelerates and Jeddah Tower Vision Takes Shapeتشكيل المشاريع العملاقة 2026 يسلّط الضوء على مرحلة التنفيذ مع تسارع أعمال إكسبو 2030 الرياض وتبلور رؤية برج جدةEpson and Classera Partner to Advance Digital Learning in Saudi Arabia’s Schoolsالسعودية: تعاون بين إبسون وكلاسيرا لتطوير التعلّم الرقمي في مدارس المملكةاليوم الوطني السعودي الـ96.. وطنٌ راسخ واقتصادٌ قوي وإعلامٌ يواكب المستقبلمتوسطة الأبناء بالرياض تحتفي باليوم الوطني 4 أيام.. والعرضة تتصدر المشهدRUA AlHaram AlMakki Expands International Collaboration Through Strategic Agreements in Malaysia and Bruneiرؤى الحرم المكي ورؤى المدينة القابضة توسعان التعاون الدولي عبر اتفاقيتين استراتيجيتين في برونايShaping Mega Projects 2026 Turns to Delivery as Expo 2030 Riyadh Accelerates and Jeddah Tower Vision Takes Shapeتشكيل المشاريع العملاقة 2026 يسلّط الضوء على مرحلة التنفيذ مع تسارع أعمال إكسبو 2030 الرياض وتبلور رؤية برج جدة
28° الرياض
English
Health

KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment

عالم يستخدم كمبيوتر لتحليل صور تحت المجهر

King Faisal Specialist Hospital & Research Centre (KFSHRC) announced a significant advancement in stem cell science, securing a U.S. patent for an innovative method that holds promise for breast cancer treatment and regenerative medicine. 

عالم يستخدم كمبيوتر لتحليل صور تحت المجهر

This innovative approach, developed by KFSHRC researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebeh, involves transforming regular breast cells into multipotent stem cells using specialized culture methods. These stem cells have shown the ability to regenerate mammary tissue in animal models, presenting new possibilities for breast tissue reconstruction and advanced cancer therapies. The foundational research supporting this patent was published in the Molecular and Cellular Biology journal.

This innovation offers a promising foundation for personalized breast cancer treatment, potentially providing enhanced reconstruction options for patients during the post-surgery period. Beyond its impact on regenerative medicine, the technique reflects KFSHRC’s dedication to advancing life-saving therapies that address the needs of cancer patients worldwide.

This patent builds on KFSHRC’s 40-year legacy in stem cell innovation, marked by over 7,649 transplants and more than 500 research publications. As a leader in advanced therapies, including localized CAR T-cell treatment for cancer, KFSHRC continues to set new standards in personalized care and transformative medical research to improve therapeutic outcomes for patients worldwide.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa